References and Notes
<A NAME="RU28905ST-1A">1a</A>
Grimmett MR.
Comprehensive Heterocyclic Chemistry
Vol. 5:
Katritzky AR.
Rees CW.
Pergamon;
Oxford:
1984.
p.345-498
<A NAME="RU28905ST-1B">1b</A>
Grimmett MR.
Comprehensive Heterocyclic Chemistry II
Vol. 3:
Katritzky AR.
Rees CW.
Scriven EFV.
Elsevier Science;
Oxford:
1996.
p.77-220
<A NAME="RU28905ST-1C">1c</A>
The Pharmacological Basis of Therapeutics
10th ed.:
Gilman AG.
Goodman LS.
Macmillan;
New York:
2001.
<A NAME="RU28905ST-1D">1d</A>
Prisinano T.
Law H.
Dukat M.
Slassi A.
MaClean N.
Demchyshyn L.
Glennon RA.
Bioorg. Med. Chem.
2001,
9:
613
For examples see:
<A NAME="RU28905ST-2A">2a</A>
Jones RCF.
Nichols JR.
Tetrahedron Lett.
1990,
31:
1771
<A NAME="RU28905ST-2B">2b</A>
Langlois Y.
Dalko PI.
J. Org. Chem.
1998,
63:
8107
<A NAME="RU28905ST-2C">2c</A>
Menges F.
Neuburger M.
Pfaltz A.
Org. Lett.
2002,
4:
4713
<A NAME="RU28905ST-2D">2d</A>
Meiere SH.
Valahovic MT.
Harman WD.
J. Am. Chem. Soc.
2002,
124:
15099
<A NAME="RU28905ST-2E">2e</A>
Bhor S.
Anilkumar G.
Tse MK.
Klawonn M.
Döbler C.
Bitterlich B.
Grotevendt A.
Beller M.
Org. Lett.
2005,
7:
3393
For examples see:
<A NAME="RU28905ST-3A">3a</A>
Ferm RJ.
Riebsomer JL.
Chem. Rev.
1954,
54:
593
<A NAME="RU28905ST-3B">3b</A>
Hughey JLIV.
Knapp S.
Schugar H.
Synthesis
1980,
489
<A NAME="RU28905ST-3C">3c</A>
Quaglia W.
Bousquet P.
Pigini M.
Carotti A.
Carrieri A.
Dontenwill M.
Gentili F.
Giannella M.
Maranca F.
Piergentili A.
Brasili L.
J. Med. Chem.
1999,
42:
2737
<A NAME="RU28905ST-3D">3d</A>
Anastassiadou M.
Baziard-Mouysset G.
Payard M.
Synthesis
2000,
1814
<A NAME="RU28905ST-3E">3e</A>
Neef G.
Eder U.
Sauer G.
J. Org. Chem.
1981,
46:
2824
<A NAME="RU28905ST-3F">3f</A>
Mitchell JM.
Finney NS.
Tetrahedron Lett.
2000,
41:
8431
<A NAME="RU28905ST-3G">3g</A>
Peddibhotla S.
Tepe JJ.
Synthesis
2003,
1433
<A NAME="RU28905ST-3H">3h</A>
You S.
Kelly JW.
Org. Lett.
2004,
6:
1681
<A NAME="RU28905ST-4">4</A>
Fujioka H.
Murai K.
Ohba Y.
Hiramatsu A.
Kita Y.
Tetrahedron Lett.
2005,
46:
2197
<A NAME="RU28905ST-5A">5a</A>
Martin PK.
Matthews HR.
Rapoport H.
Thyagarajan G.
J. Org. Chem.
1968,
33:
3758
<A NAME="RU28905ST-5B">5b</A>
Amemiya Y.
Miller DD.
Hsu FL.
Synth. Commun.
1990,
20:
2483
<A NAME="RU28905ST-5C">5c</A>
Mohammadpoor-Baltork I.
Zolfigol MA.
Abdollahi-Alibeik M.
Tetrahedron Lett.
2004,
45:
8687 ; and references cited therein
<A NAME="RU28905ST-5D">5d</A>
Mohammadpoor-Baltork I.
Zolfigol MA.
Abdollahi-Alibeik M.
Synlett
2004,
2803
<A NAME="RU28905ST-5E">5e</A>
Huh DH.
Ryu H.
Kim YG.
Tetrahedron
2004,
60:
9857
<A NAME="RU28905ST-5F">5f</A>
Nicolaou KC.
Mathison CJN.
Montagnon T.
Angew. Chem. Int. Ed.
2003,
42:
4077
<A NAME="RU28905ST-6">6</A>
Varvoglis A.
Hypervalent Iodine in Organic Synthesis
Academic Press;
San Diego:
1997.
Reviews:
<A NAME="RU28905ST-7A">7a</A>
Ochiai M.
Rev. Heteroat. Chem.
1989,
2:
92
<A NAME="RU28905ST-7B">7b</A>
Moriarty RM.
Vaid RK.
Synthesis
1990,
431
<A NAME="RU28905ST-7C">7c</A>
Moriarty RM.
Vaid RK.
Koser GF.
Synlett
1990,
365
<A NAME="RU28905ST-7D">7d</A>
Stang PJ.
Angew. Chem., Int. Ed. Engl.
1992,
31:
274
<A NAME="RU28905ST-7E">7e</A>
Prakash O.
Saini N.
Sharma PK.
Synlett
1994,
221
<A NAME="RU28905ST-7F">7f</A>
Kitamura T.
Yuki Gosei Kagaku Kyokaishi
1995,
53:
893
<A NAME="RU28905ST-7G">7g</A>
Stang PJ.
Zhdankin VV.
Chem. Rev.
1996,
96:
1123
<A NAME="RU28905ST-7H">7h</A>
Umemoto T.
Chem. Rev.
1996,
96:
1757
<A NAME="RU28905ST-7I">7i</A>
Kita Y.
Takada T.
Tohma H.
Pure Appl. Chem.
1996,
68:
627
<A NAME="RU28905ST-7J">7j</A>
Togo H.
Hoshina Y.
Nogami G.
Yokoyama M.
Yuki Gosei Kagaku Kyokaishi
1997,
55:
90
<A NAME="RU28905ST-7K">7k</A>
Varvoglis A.
Tetrahedron
1997,
53:
1179
<A NAME="RU28905ST-7L">7l</A>
Zhdankin VV.
Rev. Heteroat. Chem.
1997,
17:
133
<A NAME="RU28905ST-7M">7m</A>
Muraki T.
Togo H.
Yokoyama M.
Rev. Heteroat. Chem.
1997,
17:
213
<A NAME="RU28905ST-7N">7n</A>
Kitamura T.
Fujiwara Y.
Org. Prep. Proced. Int.
1997,
29:
409
<A NAME="RU28905ST-7O">7o</A>
Varvoglis A.
Spyroudis S.
Synlett
1998,
221
<A NAME="RU28905ST-7P">7p</A>
Zhdankin VV.
Stang PJ.
Tetrahedron
1998,
54:
10927
<A NAME="RU28905ST-7Q">7q</A>
Moriarty RM.
Prakash O.
Adv. Heterocycl. Chem.
1998,
69:
1
<A NAME="RU28905ST-7R">7r</A>
Kita Y.
Egi M.
Takada T.
Tohma H.
Synthesis
1999,
885
<A NAME="RU28905ST-7S">7s</A>
Wirth T.
Hirt UH.
Synthesis
1999,
1271
<A NAME="RU28905ST-7T">7t</A>
Ochiai M.
Kitagawa Y.
Yuki Gosei Kagaku Kyokaishi
2000,
58:
1048
<A NAME="RU28905ST-7U">7u</A>
Togo H.
Katohgi M.
Synlett
2001,
565
<A NAME="RU28905ST-7V">7v</A>
Wirth T.
Angew. Chem. Int. Ed.
2001,
40:
2812
<A NAME="RU28905ST-7W">7w</A>
Zhdankin VV.
Stang PJ.
Chem. Rev.
2002,
102:
2523
<A NAME="RU28905ST-7X">7x</A>
Togo H.
Sakuratani K.
Synlett
2002,
1966
<A NAME="RU28905ST-7Y">7y</A>
Tohma H.
Kita Y.
Adv. Synth. Catal.
2004,
346:
111
<A NAME="RU28905ST-7Z">7z</A>
Tohma H.
Kita Y.
Yuki Gosei Kagaku Kyokaishi
2004,
62:
116
<A NAME="RU28905ST-8A">8a</A>
Mori N.
Togo H.
Synlett
2004,
880
<A NAME="RU28905ST-8B">8b</A>
Mori N.
Togo H.
Tetrahedron
2005,
61:
5915
<A NAME="RU28905ST-8C">8c</A>
Mori N.
Togo H.
Synlett
2005,
1456
<A NAME="RU28905ST-9">9</A>
Typical Procedure for Preparation of 2-Imidazolines from Aldehydes: To a solution of p-tolualdehyde (120.2 mg, 1 mmol) in t-BuOH (10 mL) was added ethylenediamine (66.1 mg, 1.1 mmol). The obtained mixture
was stirred at r.t. under an argon atmosphere for 30 min, and then K2CO3 (414.6 mg, 3 mmol) and I2 (317.3 mg, 1.25 mmol) were added to the mixture and stirred at 70 °C. After 3 h,
the mixture was quenched with sat. aq Na2SO3 until the iodine color almost disappeared, and was extracted with CHCl3. The organic layer was washed with sat. aq NaHCO3 and brine, and dried over Na2SO4. After filtration, the mixture was evaporated in vacuo to provide 160.2 mg of 2-(4-methylphenyl)imidazoline
in 100% yield in an almost-pure state. Mp 181-182 °C (lit.
[11]
mp 181 °C). IR (KBr): 3140, 2925, 1600, 1495, 985, 830 cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.38 (s, 3 H), 3.77 (s, 4 H), 7.21 (d, J = 8.3 Hz, 2 H), 7.67 (d, J = 8.3 Hz, 2 H).
<A NAME="RU28905ST-10">10</A>
Typical Procedure for Oxidation of 2-Imidazolines to Imidazoles: To a mixture of 2-(4-methylphenyl)imidazoline (160.2 mg, 1 mmol) and K2CO3 (152.0 mg, 1.1 mmol) in DMSO (10 mL) was added DIB (354.3 mg, 1.1 mmol). Then the
mixture was stirred for 24 h at r.t. under an argon atmosphere. After the reaction,
the reaction mixture was diluted with sat. aq NaHCO3 and EtOAc, and was stirred for 5 min. The mixture was extracted with EtOAc and the
organic layer was dried over Na2SO4. After filtration, the mixture was evaporated in vacuo. The residue was chromatographed
on neutral silica gel (EtOAc-MeOH, 30:1) to give 128.1 mg of 2-(4-methylphenyl)imidazole
in 81% yield in an almost-pure state. Mp 217-218 °C (lit.
[5d]
mp 218-220 °C). IR (KBr): 3460, 1515, 1445, 1100, 820, 730 cm-1. 1H NMR (400 MHz, DMSO-d
6): δ = 2.31 (s, 3 H), 6.97 (br s, 1 H), 7.19 (br s, 1 H), 7.21 (d, J = 8.2 Hz, 2 H), 7.81 (d, J = 8.2 Hz, 2 H), 12.38 (s, 1 H).
<A NAME="RU28905ST-11">11</A>
Levesque G.
Synthesis
1981,
963